Clinical Trial Update: Evaluate the Clinical Benefits of EnvarsusXR in Post Liver Transplant [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update evaluating the clinical benefits of EnvarsusXR in post-liver transplant patients (Phase 2/Phase 3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation
• Postoperative Liver Transplant Complications

Drugs mentioned

• EnvarsusXR (tacrolimus extended-release)

Snippet

Sponsor: Albert Einstein Healthcare Network | Conditions: Post Liver Transplant | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING